Saúde Pública/Medicina Humanitária

Aposta de Cuba nas vacinas contra COVID produzidas no país está valendo a pena.

25 Nov, 2021 | 15:11h

Cuba’s bet on home-grown COVID vaccines is paying off – Nature

OMS lança o relatório 2021 de resistência do HIV a medicamentos.

25 Nov, 2021 | 15:10h

Comunicado de imprensa: WHO releases HIV drug resistance report 2021 – World Health Organization

Relatório: HIV drug resistance report 2021 – World Health Organization

Ficha técnica: HIV Drug Resistance – World Health Organization

Comentário no Twitter

🆕 Check out WHO’s latest HIV Drug Resistance Report & find out:

💊 how drug resistance is growing
💊 steps countries are taking to ensure people will receive effective medicine to treat & prevent HIVhttps://t.co/76teEHFrVV

— World Health Organization (WHO) (@WHO) November 24, 2021

Epidemiologia global do AVC e acesso a intervenções para AVC isquêmico agudo.

25 Nov, 2021 | 15:04h

Global Epidemiology of Stroke and Access to Acute Ischemic Stroke Interventions – Neurology

Conteúdo relacionado: Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019.

Acesso a medicamentos para câncer considerados essenciais por oncologistas em 82 países: uma pesquisa internacional transversal.

25 Nov, 2021 | 15:01h

Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey – The Lancet Oncology

Comentários:

Access to and affordability of cancer medicines: time to focus on the last mile – The Lancet Oncology

Choosing Wisely, Researchers Look at Access to Essential Cancer Drugs on a Global Scale – The ASCO Post

Conteúdos relacionados: WHO prioritizes access to diabetes and cancer treatments in new Essential Medicines Lists.

OMS emite diretrizes sobre o tratamento de crianças com síndrome inflamatória multissistêmica associada a COVID-19.

24 Nov, 2021 | 11:37h

Comunicado de imprensa: WHO issues guidelines on the treatment of children with multisystem inflammatory syndrome associated with COVID-19 – World Health Organization

Diretriz: Living guidance for clinical management of COVID-19 – World Health Organziation

Conteúdos relacionados:

An Update on Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2.

Ten Things to Know About Multisystem Inflammatory Syndrome in Children (MIS-C).

Cohort study: long term follow-up showed most patients with post–COVID-19 Multisystem Inflammatory Syndrome in Children had good outcomes with no significant medium- or long-term sequelae.

Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: An Overview and Comparison.

Cohort study: Six month follow-up of Multisystem Inflammatory Syndrome in Children.

Cohort study: Among children with Multisystem Inflammatory Syndrome (MIS-C) associated with Covid-19, there was no evidence that recovery differed after primary treatment with intravenous immune globulin (IVIG) alone, IVIG plus glucocorticoids, or glucocorticoids alone.

Cohort study: Among children with Multisystem Inflammatory Syndrome (MIS-C) associated with Covid-19, initial treatment with intravenous immune globulin (IVIG) plus glucocorticoids was associated with a lower risk of new or persistent cardiovascular dysfunction than IVIG alone.

Cohort study showed that the incidence of Multisystem Inflammatory Syndrome in Children (MIS-C) was 316 persons per 1 000 000 SARS-CoV-2 infections in persons younger than 21 years. The incidence was higher among Black, Hispanic or Latino, and Asian or Pacific Islander persons.

Cohort study showed good recovery for most children 6 months after Pediatric Inflammatory Multisystem Syndrome (PIMS-TS) associated with SARS-CoV-2.

Epidemiology of Multisystem Inflammatory Syndrome in Children: A Step Closer to Understanding Who, Where, and When

Neurologic involvement in children and adolescents with COVID-19 or Multisystem Inflammatory Syndrome

Clinical Update: Acute covid-19 and multisystem inflammatory syndrome in children

Differences in characteristics and outcomes of children and adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C) vs. severe acute COVID-19

Cutaneous findings in SARS-CoV-2-associated Multisystem Inflammatory Disease in Children (MIS-C)

SR: Multisystem inflammatory syndrome in children related to COVID-19

Observational study: The combination of Immunoglobulins + Methylprednisolone was associated with a better course of fever compared to Immunoglobulins alone in Multisystem Inflammatory Syndrome in children

ACR Guidance for pediatric patients with multisystem inflammatory syndrome in children associated with SARS‐CoV‐2

New systematic review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 infection summarizes the clinical features, management, and outcomes of the disease, showing favorable outcomes for the majority of children

Opinião de 32 ministros de saúde: o mundo precisa agir agora e se preparar para futuras emergências de saúde.

24 Nov, 2021 | 11:36h

The world must act now to be prepared for future health emergencies – The BMJ

Conteúdos relacionados:

Viewpoint | Strengthening global health security and reforming the international health regulations: making the world safer from future pandemics.

Perspective | Learning from crisis: building resilient systems to combat future pandemics.

Systematic review: Border controls, restricted entry, quarantine essential for curbing COVID-19 and future pandemics.

Opinion | The future of pandemic preparedness: agile coordination around clinical trials.

UN Report: Preventing the Next Pandemic – Zoonotic Diseases and How to Break the Chain of Transmission

Comentário no Twitter

Solidarity is key to protect the world from pandemics. This call by over 30 governments for a #PandemicTreaty to prepare for & respond to pandemics shows collaboration at work. The upcoming #WHASpecial session is a historic opportunity to make the world safer. https://t.co/98TgPce03t

— Tedros Adhanom Ghebreyesus (@DrTedros) November 23, 2021